EFFECT OF TACROLIMUS EXPOSURE ON EVEROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: A 24-MONTH ANALYSIS FROM TRANSFORM STUDY

被引：0
|
作者：
Citterio, Franco [1 ]
Peddi, V. Ram [2 ]
Qazi, Yasir [3 ]
Kim, Dean [4 ]
Vincenti, Flavio [5 ]
Berger, Stefan [6 ]
Sommerer, Claudia [7 ]
Gawai, Apurva [8 ]
Hernandez-Gutierrez, Maria-Pilar [9 ]
Bernhardt, Peter [9 ]
Oberbauer, Rainer [10 ]
机构：
[1] Sacred Heart Catholic Univ, Gemelli Univ Hosp Fdn, IRCCS, Rome, Italy
[2] Calif Pacific Med Ctr, San Francisco, CA USA
[3] Univ Southern Calif, Los Angeles, CA 90007 USA
[4] Henry Ford Hosp, Detroit, MI 48202 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Univ Med Ctr Groningen, Groningen, Netherlands
[7] Univ Hosp, Renal Clin Heidelberg, Heidelberg, Germany
[8] Novartis Healthcare Pvt Ltd, Mumbai, Maharashtra, India
[9] Novartis Pharma AG, Basel, Switzerland
[10] Med Univ Vienna, Univ Clin Internal Med 3, Vienna, Austria
来源：
TRANSPLANT INTERNATIONAL | 2021年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
POS129
引用
收藏
页码：254 / 255
页数：2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED-EXPOSURE CYCLOSPORINE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH ANALYSIS FROM THE TRANSFORM STUDY
    Sommerer, Claudia
    Pinchuk, Aleksey
    Aleman, Silvina
    Vuiblet, Vincent
    Van der Giet
    Amante, Angel Joaquin
    Han, Duck Jong
    Huynh-Do, Uyen
    Ingsathit, Atiporn
    Gawai, Apurva
    Gutierrez, Maria Pilar Hernandez
    Carmellini, Mario
    TRANSPLANTATION, 2020, 104 (09) : S622 - S623
  • [2] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Saliba, F.
    Metselaar, H. J.
    Beckebaum, S.
    Duvoux, C.
    Navasa, M.
    Dong, G.
    Lopez, P.
    Nevens, F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S79 - S80
  • [3] ASSESSMENT OF PROTEINURIA REPORTED AS ADVERSE EVENTS IN DE NOVO RENAL TRANSPLANT RECIPIENTS RECEIVING AN EVEROLIMUS-BASED REGIMEN: 24-MONTH RESULTS FROM TRANSFORM
    Legendre, C.
    Buchler, M.
    Pernin, V.
    Berger, S. P.
    Oppenheimer, F.
    Wiseman, A.
    Viklicky, O.
    Russ, G. R.
    Danguilan, R.
    Basic-Jukic, N.
    Mor, E.
    Narvekar, P.
    Hernandez-Gutierrez, M. P.
    Bernhardt, P.
    Gharbi, H.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 5 - 5
  • [4] Exposure-Response Analysis of Everolimus and Tacrolimus in De Novo Liver Transplant Recipients: 24-Month Results from the H2304 Study.
    Fischer, L.
    Kaiser, G. M.
    Huang, M. A.
    Toselli, L.
    Durand, F.
    Heaton, N.
    Shetty, K.
    Klintmalm, G.
    Dong, G.
    Lopez, P.
    Junge, G.
    Kovarik, J. M.
    LIVER TRANSPLANTATION, 2013, 19 : S148 - S148
  • [5] EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Kaiser, G. M.
    Saliba, F.
    Jonas, S.
    Duvoux, C.
    Dong, G.
    Junge, G.
    Lopez, P.
    De Simone, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S12 - S12
  • [6] Assessment of Proteinuria Reported as Adverse Events in De Novo Renal Transplant Recipients Receiving an Everolimus-Based Regimen: 24-Month Results from TRANSFORM.
    Legendre, C.
    Berger, S.
    Oppenheimer, F.
    Wiseman, A.
    Steinberg, S.
    Viklicky, O.
    Russ, G.
    Danguilan, R.
    Basic-Jukic, N.
    Mor, E.
    Narvekar, P.
    Gutierrez, M. P. Hernandez
    Bernhardt, P.
    Sommerer, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 693 - 694
  • [7] Psychiatric Morbidity in De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression
    Buerker, B. S.
    Malt, U. F.
    Gude, E.
    Gullestad, L.
    Relbo, A.
    Grov, I.
    Andreassen, A. K.
    Fiane, A. E.
    Haraldsen, I. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S288 - S289
  • [8] EFFICACY AND SAFETY OF EVEROLIMUS-BASED REGIMEN IN RENAL TRANSPLANT RECIPIENTS WITH DELAYED GRAFT FUNCTION: 24-MONTH RESULTS FROM THE TRANSFORM STUDY
    Citterio, Franco
    Sommerer, Claudia
    Oppenheimer, Federico
    Berger, Stefan
    Viklicky, Ondrej
    Danguilan, Romina
    Basic-Jukic, Nikolina
    Hernandez, Maria-Pilar
    Narvekar, Prachiti
    Bernhardt, Peter
    Legendre, Christophe
    TRANSPLANT INTERNATIONAL, 2019, 32 : 80 - 80
  • [9] Cognitive Functioning Among De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression
    Buerker, B. S.
    Andersson, S.
    Gullestad, L.
    Gude, E.
    Relbo, A.
    Grov, I.
    Malt, U. F.
    Andreassen, A. K.
    Fiane, A. E.
    Haraldsen, I. H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S239 - S239
  • [10] De Novo Everolimus-Based Immunosuppression in Liver Transplant Recipients; Retrospective Analysis of Safety and Efficacy.
    Nicolini, Daniele
    Del Pozo, Ana Carolina
    Di Giuseppe, Jacopo
    Vivarelli, Marco
    Garelli, Paolo
    Martorelli, Giacomo
    Vincenzi, Paolo
    Federici, Alen
    Gentili, Marco
    De Luca, Stefano
    Vecchi, Andrea
    Risaliti, Andrea
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 530 - 530
12345